AbstractGlioblastoma multiforme (GBM) is a highly malignant human brain tumour for which no cure is available at present. Numerous clinical studies as well as animal experiments are under way with the goal being to understand tumour biology and develop potential therapeutic approaches. C6 cell glioma in the adult rat is a frequently used and well accepted animal model for the malignant human glial tumour. By combining standard analytical methods such as histology and immunohistochemistry with Fourier Transform Infrared (FTIR) microspectroscopic imaging and multivariate statistical approaches, we are developing a novel approach to tumour diagnosis which allows us to obtain information about the structure and composition of tumour tissues tha...
AbstractThe purpose of this study was to investigate molecular changes associated with glioma tissue...
The management of cancer patients has markedly improved with the advent of personalised medicine whe...
Over a third of brain tumour patients visit their general practitioner more than five times prior to...
AbstractGlioblastoma multiforme (GBM) is a highly malignant human brain tumour for which no cure is ...
AbstractPathological changes associated with the development of brain tumor were investigated by Fou...
International audienceGliomas are brain tumours classified into four grades with increasing malignan...
As a molecular probe of tissue composition, IR spectroscopy can potentiallyserve as an adjunct to hi...
Gliomas are the most frequent primary brain tumors. Their malignancies are graded from 1 to 4. Malig...
The most common initial treatment received by patients with a brain tumour is surgical removal of th...
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, characterized by short median surv...
Fourier-transform infrared (FT-IR) spectral imaging was used for analyzing biochemical changes in tu...
IR spectra of breast tumor cell lines and breast tumor tissues have been measured. IR measurements o...
Glioblastoma multiforme (GBM) is a particularly malignant primary brain tumor. Despite enormous adva...
AbstractFourier-transform infrared (FT-IR) spectral imaging was used for analyzing biochemical chang...
The management of cancer patients has markedly improved with the advent of personalised medicine whe...
AbstractThe purpose of this study was to investigate molecular changes associated with glioma tissue...
The management of cancer patients has markedly improved with the advent of personalised medicine whe...
Over a third of brain tumour patients visit their general practitioner more than five times prior to...
AbstractGlioblastoma multiforme (GBM) is a highly malignant human brain tumour for which no cure is ...
AbstractPathological changes associated with the development of brain tumor were investigated by Fou...
International audienceGliomas are brain tumours classified into four grades with increasing malignan...
As a molecular probe of tissue composition, IR spectroscopy can potentiallyserve as an adjunct to hi...
Gliomas are the most frequent primary brain tumors. Their malignancies are graded from 1 to 4. Malig...
The most common initial treatment received by patients with a brain tumour is surgical removal of th...
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, characterized by short median surv...
Fourier-transform infrared (FT-IR) spectral imaging was used for analyzing biochemical changes in tu...
IR spectra of breast tumor cell lines and breast tumor tissues have been measured. IR measurements o...
Glioblastoma multiforme (GBM) is a particularly malignant primary brain tumor. Despite enormous adva...
AbstractFourier-transform infrared (FT-IR) spectral imaging was used for analyzing biochemical chang...
The management of cancer patients has markedly improved with the advent of personalised medicine whe...
AbstractThe purpose of this study was to investigate molecular changes associated with glioma tissue...
The management of cancer patients has markedly improved with the advent of personalised medicine whe...
Over a third of brain tumour patients visit their general practitioner more than five times prior to...